Brief: Inmune Bio And Anthony Nolan Announce Strategic Expansion
05/05/2026 21:37
May 5 (Reuters) - INmune Bio Inc INMB.O: INMUNE BIO AND ANTHONY NOLAN ANNOUNCE STRATEGIC EXPANSION OF CORDSTROM™ MSC PLATFORM COLLABORATION TO TARGET RDEB, ONCOLOGY, AND INFLAMMATORY DISEASES Source text: ID:nGNXcbcVtX Further company coverage: INMB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inmune Bio
See all newsBrief: Inmune Bio - Enters Master Services Agreement With Uniphar For Ebstrocel International Commercialization
Brief: Inmune Bio Targets UK Maa In Q4 2026, EU Maa And US BLA In Q1 2027
INmune Bio Inc reports results for the quarter ended June 30 - Earnings Summary
INmune Bio Q2 net loss narrows on lower impairment charges
INmune Bio Inc expected to post a loss of 21 cents a share - Earnings Preview